Univest
Univest
  • Markets

Wockhardt (WOCKPHARMA) Share Price Falls 2.06% to Rs 1,867.10; Large Cap Pharma Stock Trades Lower

  • September 1, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Wockhardt Share Price
Wockhardt (WOCKPHARMA) share price fell to Rs 1,867.1 today, down 2.06% from the previous close. Market cap was Rs 30,978.32 crore.

Wockhardt Share Price was at Rs 1,867.10, down 2.06% today, with market capitalisation at Rs 30,978.32 crore. The stock moved lower in the latest session after opening at Rs 1,913.55, touching a high of Rs 1,922.85 and a low of Rs 1,864.60 as of 21 October 2026 at 12:22:53 PM IST. Univest data confirms the move itself, though no company-specific trigger has been identified. The move keeps Wockhardt Share Price in focus for investors tracking Wockhardt Share Price Today, Wockhardt Stock News and Wockhardt Share Price Fall alongside valuation and sector context.

For readers following Wockhardt Share Price, the key point is straightforward: the stock is trading below the previous close of Rs 1,906.45, and the day’s range shows that the decline has extended close to the low of the day. Wockhardt Share Price remains relevant because it is a Large Cap company in Healthcare, and its fundamental metrics sit well above the industry median on valuation, even as profitability ratios remain modest. That combination is why Wockhardt Share Price Today attracts attention in stock news coverage and fundamental analysis discussion.

Table of Contents

Toggle
  • Wockhardt (WOCKPHARMA) Share Price Today: Price Action Analysis
  • Wockhardt (WOCKPHARMA) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Wockhardt
  • About Wockhardt
  • Track Wockhardt Share Price on Univest
  • Frequently Asked Questions
    • Why is Wockhardt Share Price falling today?
    • What is the current Wockhardt Share Price today?
    • How much did Wockhardt Share Price decline today?
    • Is Wockhardt a Large Cap stock?
    • How does Wockhardt Share Price compare with the healthcare benchmark?
    • What do EPS and book value show for Wockhardt Share Price?
    • Does Wockhardt pay a dividend?
    • How does Wockhardt compare with peers on valuation?
    • What should investors monitor next in Wockhardt Share Price?

Wockhardt (WOCKPHARMA) Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 1,867.1
Previous Close Rs 1,906.45
Today's Move -Rs 39.35 (-2.06%)
Open Rs 1,913.55
High Rs 1,922.85
Low Rs 1,864.6
Market Capitalisation Rs 30,978.32 crore
Market Cap Category Large Cap

Wockhardt Share Price Today reflects a single-session decline of Rs 39.35. The stock traded at Rs 1,867.10 versus the previous close of Rs 1,906.45, which places the move at -2.06% on the day. Wockhardt Share Price opened at Rs 1,913.55 and reached an intraday high of Rs 1,922.85 before slipping to a low of Rs 1,864.60. The gap between the opening level and the low shows that the share price fall developed during trading rather than staying confined to the opening print.

Market capitalisation stands at Rs 30,978.32 crore, and the company is classified as Large Cap. That size matters for context because Wockhardt Share Price is being assessed within a larger listed healthcare business rather than a smaller speculative name. The day’s decline also places Wockhardt Share Price back in the range that investors often watch for follow-through in Stock Market Today commentary. The latest Wockhardt Share Price signal is therefore a clear price action event first, with fundamentals providing the next layer of context.

Wockhardt (WOCKPHARMA) Fundamental Analysis

Metric Value
Market Capitalisation Rs 30,978.32 crore
P/E Ratio 75.74x
P/B Ratio 6.15x
ROE 4.29%
ROCE 6.79%
EPS Rs 25.17
Book Value Per Share Rs 309.81
Dividend Yield 0%

Wockhardt (WOCKPHARMA) fundamental metrics show P/E 75.74x, P/B 6.15x, ROE 4.29%, ROCE 6.79%. Read together, these ratios describe the company’s position rather than a recommendation.

Wockhardt has a market capitalisation of Rs 30,978.32 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 75.74x, P/B at 6.15x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.29% and ROCE of 6.79%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 25.17, book value per share of Rs 309.81, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.73x, median ROE of 11.33%, median ROCE of 13.25%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 75.74x
Benchmark Median P/E 31.73x
Benchmark Average P/E 45.98x
Benchmark P/E Range 3.1x to 616.89x
Company P/B Ratio 6.15x
Benchmark Median P/B 2.76x
Benchmark Average P/B 4.11x
Company ROE 4.29%
Benchmark Median ROE 11.33%
Benchmark Average ROE 10.14%
Company ROCE 6.79%
Benchmark Median ROCE 13.25%
Benchmark Average ROCE 13.05%
Company Market Capitalisation Rs 30,978.32 crore
Benchmark Median Market Cap Rs 771.43 crore
Benchmark Average Market Cap Rs 13,467.03 crore

Wockhardt (WOCKPHARMA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Wockhardt (WOCKPHARMA) has a P/E ratio of 75.74x, which is above the benchmark median of 31.73x, a difference of +138.7%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Wockhardt (WOCKPHARMA) has a ROE of 4.29%, which is below the benchmark median of 11.33%, a difference of -62.14%. Wockhardt (WOCKPHARMA) has a ROCE of 6.79%, which is below the benchmark median of 13.25%, a difference of -48.75%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries SUNPHARMA 4,18,683.95 34.61 4.84 14.85 19.11
Divi's Laboratories DIVISLAB 2,41,310.94 82.5 13.66 16.19 21.51
Torrent Pharmaceuticals TORNTPHARM 1,73,078.79 79.36 19.28 26.76 19.27
Laurus Labs LAURUSLABS 1,11,433.99 101.92 19.76 18.31 18.2
Zydus Lifesciences ZYDUSLIFE 1,11,022.18 24.6 4.12 19.69 21.39

Wockhardt (WOCKPHARMA) has a P/E ratio of 75.74x compared with the displayed peer median of 79.36x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 4.29% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 6.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Wockhardt (WOCKPHARMA) has a market capitalisation of Rs 30,978.32 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Wockhardt

  • Wockhardt Share Price fell 2.06% today, so the latest price action is the first thing investors are tracking.
  • The stock trades at a P/E of 75.74 and P/B of 6.15, both above the industry median in the same industry set.
  • ROE of 4.29% and ROCE of 6.79% are below the healthcare benchmark, which keeps Wockhardt Share Price under valuation scrutiny.
  • Market capitalisation of Rs 30,978.32 crore places Wockhardt in the Large Cap category and adds scale context.
  • According to Univest data, no company-specific catalyst is established for the day’s move, so investors are watching price action and peer comparison.

About Wockhardt

Wockhardt is a Healthcare company in the Pharmaceuticals & Drugs industry. The business operates in a listed Large Cap profile and is followed for its share price, valuation and operating return ratios. In this market context, Wockhardt Share Price is shaped by both the company’s scale and the premium multiple at which it trades. The name is part of the broader Indian pharma universe that includes large diversified formulation businesses and research-led peers. For readers tracking Wockhardt Company News, the company belongs to a sector where earnings quality, profitability and valuation are typically compared closely across listed peers.

Track Wockhardt Share Price on Univest

Use Wockhardt (WOCKPHARMA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

You can track Wockhardt Share Price on Univest for live updates, fundamental ratios, 52-week levels and market insights in one place. The platform also helps you follow Wockhardt Stock News, Wockhardt Latest News and Wockhardt Share Price Update with peer context and company details. For investors reviewing Wockhardt Share Price Today, Univest keeps the focus on verified data, valuation context and sector comparison.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Wockhardt Share Price falling today?

Ans. Wockhardt Share Price is down 2.06% today to Rs 1,867.10. The data confirms the fall, but no company-specific catalyst is established, so the analysis rests on price action and valuation context.

What is the current Wockhardt Share Price today?

Ans. Wockhardt Share Price is trading at Rs 1,867.10 as of 21 October 2026 at 12:22:53 PM IST. It is below the previous close of Rs 1,906.45 and has moved within a range of Rs 1,864.60 to Rs 1,922.85.

How much did Wockhardt Share Price decline today?

Ans. Wockhardt Share Price declined by Rs 39.35, which equals -2.06% from the previous close. The stock opened at Rs 1,913.55, so the day’s move was measured after a higher opening level.

Is Wockhardt a Large Cap stock?

Ans. Yes. Wockhardt is classified as a Large Cap company with a market capitalisation of Rs 30,978.32 crore. That size context matters when reading Wockhardt Share Price and comparing it with healthcare peers.

How does Wockhardt Share Price compare with the healthcare benchmark?

Ans. Wockhardt Share Price trades at a P/E of 75.74 and a P/B of 6.15, both above the industry median. Its ROE of 4.29% and ROCE of 6.79% are below the benchmark median for the same industry set.

What do EPS and book value show for Wockhardt Share Price?

Ans. EPS is Rs 25.17, which shows earnings attributable to each share. Book value is Rs 309.81 per share, which reflects the accounting net worth behind each share and helps frame Wockhardt Share Price valuation.

Does Wockhardt pay a dividend?

Ans. Dividend yield is 0%, so the current data does not show a dividend payout signal. For Wockhardt Share Price, that means investors are mainly reading valuation, return ratios and price action rather than yield support.

How does Wockhardt compare with peers on valuation?

Ans. Wockhardt Share Price has a P/E of 75.74, above Sun Pharmaceutical Industries and Cipla, but below Divi's Laboratories and Laurus Labs Its P/B of 6.15 is also above several peers in the same group.

What should investors monitor next in Wockhardt Share Price?

Ans. Investors should monitor whether Wockhardt Share Price holds around the current range, how valuation compares with peers, and whether future company updates change the earnings and return-ratio picture. Univest can be used to track the next move.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply